Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Pretreatment fibrinogen levels

  • You have access
    Pretreatment Fibrinogen Level Is a Prognostic Factor for Esophageal Cancer Patients Who Receive Curative Treatment
    TORU AOYAMA, AYA KATO, ITARU HASHIMOTO, YUKIO MAEZAWA, KENTARO HARA, SHINNOSUKE KAWAHARA, KEISUKE KAZAMA, KEISUKE KOMORI, SUZUE YOSHIZAWA, AYAKO TAMAGAWA, MINORI TATEISHI, TOMOYUKI MINAMI, HARUHIKO CHO, JUNYA MORITA, KAZUKI OTANI, SHO SAWAZAKI, MASAKATAU NUMATA, MIE TANABE, TAKASHI OSHIMA, AYA SAITO, NORIO YUKAWA and YASUSHI RINO
    Anticancer Research January 2024, 44 (1) 249-255; DOI: https://doi.org/10.21873/anticanres.16808
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire